Investments
10Portfolio Exits
4Latest JGB Management News
Mar 14, 2022
NBEV used this facility to repay in full its existing outstanding loan balance of $10.6M under its 8% senior secured note with JGB Management. The remaining availability on the new facility will be used for general working capital purposes. The new line of credit bears interest at Prime plus 1.75%, and is interest-only until Mar. 2024. "This new credit facility successfully retires the $30M senior secured debt used to fund a portion of the ARIIX acquisition and enhances our liquidity profile," said NBEV interim CEO Ed Brennan. To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser. If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.
JGB Management Investments
10 Investments
JGB Management has made 10 investments. Their latest investment was in Cascadian Therapeutics as part of their PIPE on February 2, 2011.
JGB Management Investments Activity
JGB Management Portfolio Exits
4 Portfolio Exits
JGB Management has 4 portfolio exits. Their latest portfolio exit was Cascadian Therapeutics on March 09, 2018.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
3/9/2018 | Acq - P2P | 4 | |||
Date | 3/9/2018 | |||
|---|---|---|---|---|
Exit | Acq - P2P | |||
Companies | ||||
Valuation | ||||
Acquirer | ||||
Sources | 4 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.